Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.

Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Drug Approval Feed Articles ...

Sandoz proposed biosimilars recommended for EU approval
https://www.europeanpharmaceuticalreview.com, , 25-Apr-2017
Antipsychotic drug could help reduce nausea and vomiting caused by chemotherapy
http://www.med-chemist.com, , 25-Apr-2017
FDA Clears Second Remicade Biosimilar
http://www.rxlist.com, , 25-Apr-2017
Mechanistic insights into epigenetic modulation of ethanol consumption.
Medline, Alcohol (Fayetteville, N.Y.), 25-Apr-2017
Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses.
Medline, European journal of medicinal chemistry [135] 70-76, 25-Apr-2017
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
ClinicalTrials.gov, , 25-Apr-2017
An Open-labeled, Multi-Center, Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy
ClinicalTrials.gov, , 25-Apr-2017
A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
ClinicalTrials.gov, , 25-Apr-2017
Hearing Outcomes Using Super-power Processors in Bone Anchored Implant Recipients
ClinicalTrials.gov, , 25-Apr-2017
REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)
ClinicalTrials.gov, , 25-Apr-2017
Effect of CCR5 Inhibition by Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant for Any Indication and Its Observed Effect on Graft Versus Host Disease and HIV-1 Persistence
ClinicalTrials.gov, , 25-Apr-2017
Phase I Trial of Intravenous Administration of Vesicular Stomatitis Virus Genetically Engineered to Express Thyroidal Sodium Iodide Symporter (NIS) and Human Interferon Beta (hIFNb) in Patients With Metastatic or Recurrent Endometrial Cancer
ClinicalTrials.gov, , 25-Apr-2017
Return of Amyloid Imaging Results
ClinicalTrials.gov, , 25-Apr-2017
Early Imaging Biomarkers to Predict Radiation-Induced Cardiopulmonary Toxicity in Patients With Thoracic Malignancies
ClinicalTrials.gov, , 25-Apr-2017
Biomarker-Driven Phase 2 Study of Nivolumab in Advanced Metastatic NSCLC
ClinicalTrials.gov, , 25-Apr-2017
A Phase II Study of Blinatumomab in Richter Transformation
ClinicalTrials.gov, , 25-Apr-2017
Pressure-Volume Measurements on the AMS 800TM Cuff
ClinicalTrials.gov, , 25-Apr-2017
Phase II Study to Assess the Efficacy of Durvalumab (MEDI4736) and Tremelimumab Plus Radiotherapy or Ablation in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov, , 25-Apr-2017
Expanded Access to Venetoclax
ClinicalTrials.gov, , 25-Apr-2017
Expanded Access to Veliparib
ClinicalTrials.gov, , 25-Apr-2017
Showing Records 0 ... 20  

The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts


Query: Drug Approval Feed
Type: Query